Low RKIP expression associates with poor prognosis in bladder cancer patients
Urothelial bladder cancer (UBC) is a heterogeneous type of disease. It is urgent to screen biomarkers of tumour aggressiveness in order to clarify the clinical behaviour and to personalize therapy in UBC patients. Raf kinase inhibitory protein (RKIP) is a metastasis suppressor, and its downregulatio...
Main Author: | |
---|---|
Other Authors: | , , , , , |
Format: | article |
Language: | eng |
Published: |
2013
|
Subjects: | |
Online Access: | http://hdl.handle.net/1822/33584 |
Country: | Portugal |
Oai: | oai:repositorium.sdum.uminho.pt:1822/33584 |